IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.

Source:http://linkedlifedata.com/resource/pubmed/id/14500898

Proc. Natl. Acad. Sci. U.S.A. 2003 Sep 30 100 20 11630-5

Download in:

View as

General Info

PMID
14500898